US Pharma MarketingThe post AbCellera reports favourable Phase II data for ABCL635 appeared first on Clinical Trials Arena.
AbCellera reports favourable Phase II data for ABCL635
AbCellera has reported encouraging top-line data from the Phase II segment of its Phase I/II study assessing ABCL635. The post AbCellera reports favourable Phase II data for ABCL635 appeared first on Clinical Trials Arena .
AbCellera has reported encouraging top-line data from the Phase II segment of its Phase I/II study assessing ABCL635.
Source: Clinical Trials Arena